Management of tracheal and bronchial stenoses with the Gianturco stent.
作者信息
Carrasco C H, Nesbitt J C, Charnsangavej C, Ryan B, Walsh G L, Yasumori K, Lawrence D D, Wallace S
机构信息
Department of Diagnostic Radiology, University of Texas M.D. Anderson Cancer Center, Houston.
出版信息
Ann Thorac Surg. 1994 Oct;58(4):1012-6; discussion 1017. doi: 10.1016/0003-4975(94)90446-4.
Thirty-six cancer patients with symptomatic tracheobronchial stenoses received Gianturco tracheobronchial stents over a 9-year period. Symptoms improved in 28 patients (78%). The overall median survival was 1 month 3 weeks (range, 4 days to 35 months). The median survival for patients who showed improvement after receiving stents was 3 months compared with 1 week for those who did not respond. Complications were minimal. The Gianturco stent may palliate symptoms of tracheobronchial compression in selected cancer patients.
Zotero 插件